NIKOLA SPRIGG nikola.sprigg@nottingham.ac.uk
Professor of Stroke Medicine
Speeding stroke recovery? A systematic review of amphetamine after stroke
Sprigg, Nikola; Bath, Philip M.W.
Authors
PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine
Abstract
Introduction: The use of drugs to enhance recovery (“rehabilitation pharmacology”) has been assessed. Amphetamine can improve outcome in experimental models of stroke, and several small clinical trials have assessed its use in stroke.
Methods: Electronic searches were performed to identify randomised controlled trials of amphetamine in stroke (ischaemic or haemorrhagic). Outcomes included functional outcome (assessed as combined death or disability/dependency), safety (death) and haemodynamic measures. Data were analysed as dichotomous or continuous outcomes, using odds ratios (OR), weighted or standardised mean difference, (WMD or SMD) using random-effects models with 95% confidence intervals (95% CI); statistical heterogeneity was assessed. Results: Eleven completed trials (n=329) were identified. Treatment with amphetamine was associated with non-significant trends to increased death (OR 2.78 (95% CI, 0.75–10.23), n=329, 11 trials) and improved motor scores (WMD 3.28 (95% CI −0.48–7.04) n=257, 9 trials) but had no effect on the combined outcome of death and dependency (OR 1.15 (95% CI 0.65–2.06, n=206, 5 trials). Amphetamine increased systolic blood pressure (WMD 9.3 mmHg, 95% CI 3.3–15.3, n=106, 3 trials) and heart rate (WMD 7.6 beats per minute (bpm), 95% CI 1.8–13.4, n=106, 3 trials). Despite variations in treatment regimes, outcomes and follow-up duration there was no evidence of significant heterogeneity or publication bias.
Conclusion: No evidence exists at present to support the use of amphetamine after stroke. Despite a trend to improved motor function, doubts remain over safety and there are significant haemodynamic effects, the consequences of which are unknown.
Citation
Sprigg, N., & Bath, P. M. (2009). Speeding stroke recovery? A systematic review of amphetamine after stroke. Journal of the Neurological Sciences, 285(1-2), 3-9. https://doi.org/10.1016/j.jns.2009.04.040
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 16, 2009 |
Online Publication Date | May 19, 2009 |
Publication Date | Oct 15, 2009 |
Deposit Date | Jun 4, 2009 |
Publicly Available Date | Jun 4, 2009 |
Journal | Journal of the Neurological Sciences |
Print ISSN | 0022-510X |
Electronic ISSN | 0022-510X |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 285 |
Issue | 1-2 |
Pages | 3-9 |
DOI | https://doi.org/10.1016/j.jns.2009.04.040 |
Public URL | https://nottingham-repository.worktribe.com/output/1014872 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0022510X09005711?via%3Dihub |
Contract Date | Jun 4, 2009 |
Files
AmphetamineSRJNSrev_sprigg_09.pdf
(172 Kb)
PDF
You might also like
Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search